{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T22:53:34Z","timestamp":1778626414552,"version":"3.51.4"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010256","name":"Guangzhou Municipal Science and Technology Project","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010256","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.bcp.2019.113762","type":"journal-article","created":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T20:31:00Z","timestamp":1576269060000},"page":"113762","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["A mutation of cysteine 46 in IKK-\u03b2 promotes mPGES-1 and caveolin-1 expression to exacerbate osteoclast differentiation and osteolysis"],"prefix":"10.1016","volume":"172","author":[{"given":"Binhua","family":"Zou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yueyang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2339-5901","authenticated-orcid":false,"given":"Ting","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wende","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanhui","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zongbao","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kangsheng","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jialan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hudan","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.bcp.2019.113762_b0005","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1007\/s10067-010-1635-8","article-title":"Introduction to economic modeling for clinical rheumatologists: application to biologic agents in rheumatoid arthritis","volume":"30","author":"Marra","year":"2011","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.bcp.2019.113762_b0010","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.intimp.2018.10.016","article-title":"Monocytes in rheumatoid arthritis: circulating precursors of macrophages and osteoclasts and their heterogeneity and plasticity role in RA pathogenesis","volume":"65","author":"Rana","year":"2018","journal-title":"Int. Immunopharmacol."},{"issue":"8","key":"10.1016\/j.bcp.2019.113762_b0015","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1358\/dnp.2010.23.8.1447844","article-title":"Targeting IKKbeta for the treatment of rheumatoid arthritis","volume":"23","author":"Bamborough","year":"2010","journal-title":"Drug News Perspect."},{"issue":"6","key":"10.1016\/j.bcp.2019.113762_b0020","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1002\/jcb.22364","article-title":"Impediment of NEMO oligomerization inhibits osteoclastogenesis and osteolysis","volume":"108","author":"Darwech","year":"2009","journal-title":"J. Cell Biochem."},{"issue":"6","key":"10.1016\/j.bcp.2019.113762_b0025","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/jbm4.10058","article-title":"Comparative characterization of osteoclasts derived from murine bone marrow macrophages and RAW 264.7 cells using quantitative proteomics","volume":"2","author":"Ng","year":"2018","journal-title":"JBMR Plus"},{"issue":"1","key":"10.1016\/j.bcp.2019.113762_b0030","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/14397595.2017.1369491","article-title":"RANKL: a therapeutic target for bone destruction in rheumatoid arthritis","volume":"28","author":"Tanaka","year":"2018","journal-title":"Mod. Rheumatol."},{"issue":"1","key":"10.1016\/j.bcp.2019.113762_b0035","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s00223-013-9735-5","article-title":"Ubiquitin-like domain of IKKbeta regulates osteoclastogenesis and osteolysis","volume":"93","author":"Zhang","year":"2013","journal-title":"Calcif. Tissue Int."},{"issue":"33","key":"10.1016\/j.bcp.2019.113762_b0040","doi-asserted-by":"crossref","first-page":"25522","DOI":"10.1074\/jbc.M110.121533","article-title":"Tyrosine phosphorylation is required for IkappaB kinase-beta (IKKbeta) activation and function in osteoclastogenesis","volume":"285","author":"Darwech","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.bcp.2019.113762_b0045","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1002\/jbmr.4","article-title":"IKKbeta activation is sufficient for RANK-independent osteoclast differentiation and osteolysis","volume":"25","author":"Otero","year":"2010","journal-title":"J. Bone Miner. Res."},{"issue":"4","key":"10.1016\/j.bcp.2019.113762_b0050","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.phymed.2016.01.006","article-title":"NF-kappaB pathway inhibition by anthrocyclic glycoside aloin is key event in preventing osteoclastogenesis in RAW264.7 cells","volume":"23","author":"Pengjam","year":"2016","journal-title":"Phytomedicine"},{"issue":"10","key":"10.1016\/j.bcp.2019.113762_b0055","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1084\/jem.20042081","article-title":"I{kappa}B kinase (IKK){beta}, but not IKK{alpha}, is a critical mediator of osteoclast survival and is required for inflammation-induced bone loss","volume":"201","author":"Ruocco","year":"2005","journal-title":"J. Exp. Med."},{"issue":"Suppl 4","key":"10.1016\/j.bcp.2019.113762_b0060","first-page":"iv81-5","article-title":"IKK{beta} as a target for treatment of inflammation induced bone loss","volume":"64","author":"Ruocco","year":"2005","journal-title":"Ann. Rheum. Dis."},{"issue":"12","key":"10.1016\/j.bcp.2019.113762_b0065","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/j.bcp.2013.09.017","article-title":"SC-514, a selective inhibitor of IKKbeta attenuates RANKL-induced osteoclastogenesis and NF-kappaB activation","volume":"86","author":"Liu","year":"2013","journal-title":"Biochem. Pharmacol."},{"issue":"2","key":"10.1016\/j.bcp.2019.113762_b0070","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/s00223-018-0406-4","article-title":"Pharmacological inhibition of the skeletal IKKbeta reduces breast cancer-induced osteolysis","volume":"103","author":"Marino","year":"2018","journal-title":"Calcif. Tissue Int."},{"issue":"10","key":"10.1016\/j.bcp.2019.113762_b0075","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/nri1703","article-title":"NF-kappaB: linking inflammation and immunity to cancer development and progression","volume":"5","author":"Karin","year":"2005","journal-title":"Nat. Rev. Immunol."},{"issue":"11","key":"10.1016\/j.bcp.2019.113762_b0080","doi-asserted-by":"crossref","first-page":"7852","DOI":"10.4049\/jimmunol.179.11.7852","article-title":"Amelioration of chronic murine colitis by peptide-mediated transduction of the IkappaB kinase inhibitor NEMO binding domain peptide","volume":"179","author":"Dave","year":"2007","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.bcp.2019.113762_b0085","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.4049\/jimmunol.179.5.2681","article-title":"Cutting edge: the IkappaB kinase (IKK) inhibitor, NEMO-binding domain peptide, blocks inflammatory injury in murine colitis","volume":"179","author":"Shibata","year":"2007","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.bcp.2019.113762_b0090","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1124\/jpet.109.158899","article-title":"Inhibition of inflammatory cytokine production from rheumatoid synovial fibroblasts by a novel IkappaB kinase inhibitor","volume":"333","author":"Tsuchiya","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"2","key":"10.1016\/j.bcp.2019.113762_b0095","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/cei.12054","article-title":"Intra-articular nuclear factor-kappaB blockade ameliorates collagen-induced arthritis in mice by eliciting regulatory T cells and macrophages","volume":"172","author":"Min","year":"2013","journal-title":"Clin. Exp. Immunol."},{"issue":"3","key":"10.1016\/j.bcp.2019.113762_b0100","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.3892\/or.2016.4915","article-title":"IKK inhibitor suppresses epithelial-mesenchymal transition and induces cell death in prostate cancer","volume":"36","author":"Ping","year":"2016","journal-title":"Oncol. Rep."},{"issue":"31","key":"10.1016\/j.bcp.2019.113762_b0105","doi-asserted-by":"crossref","first-page":"31805","DOI":"10.18632\/oncotarget.5567","article-title":"Mutation of cysteine 46 in IKK-beta increases inflammatory responses","volume":"6","author":"Li","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.bcp.2019.113762_b0110","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.bcp.2016.10.007","article-title":"Artesunate suppresses RANKL-induced osteoclastogenesis through inhibition of PLCgamma1-Ca(2+)-NFATc1 signaling pathway and prevents ovariectomy-induced bone loss","volume":"124","author":"Zeng","year":"2017","journal-title":"Biochem. Pharmacol."},{"issue":"6","key":"10.1016\/j.bcp.2019.113762_b0115","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/01.rhu.0000147138.11053.e4","article-title":"Basic science for the clinician 33: interleukins of current clinical relevance (part I)","volume":"10","author":"Sigal","year":"2004","journal-title":"J. Clin. Rheumatol."},{"issue":"5","key":"10.1016\/j.bcp.2019.113762_b0120","doi-asserted-by":"crossref","first-page":"R111","DOI":"10.1186\/ar4291","article-title":"Bacterial lipopolysaccharides form procollagen-endotoxin complexes that trigger cartilage inflammation and degeneration: implications for the development of rheumatoid arthritis","volume":"15","author":"Lorenz","year":"2013","journal-title":"Arthritis. Res. Ther."},{"issue":"4","key":"10.1016\/j.bcp.2019.113762_b0125","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00418-018-1636-2","article-title":"Recent advances in osteoclast biology","volume":"149","author":"Ono","year":"2018","journal-title":"Histochem. Cell Biol."},{"issue":"6937","key":"10.1016\/j.bcp.2019.113762_b0130","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature01658","article-title":"Osteoclast differentiation and activation","volume":"423","author":"Boyle","year":"2003","journal-title":"Nature"},{"issue":"14","key":"10.1016\/j.bcp.2019.113762_b0135","doi-asserted-by":"crossref","first-page":"13984","DOI":"10.1074\/jbc.M213067200","article-title":"The calcineurin\/nuclear factor of activated T cells signaling pathway regulates osteoclastogenesis in RAW264.7 cells","volume":"279","author":"Hirotani","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"25","key":"10.1016\/j.bcp.2019.113762_b0140","doi-asserted-by":"crossref","first-page":"26475","DOI":"10.1074\/jbc.M313973200","article-title":"Nuclear factor of activated T-cells (NFAT) rescues osteoclastogenesis in precursors lacking c-Fos","volume":"279","author":"Matsuo","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.bcp.2019.113762_b0145","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/jbmr.531","article-title":"Regulation of human osteoclast development by dendritic cell-specific transmembrane protein (DC-STAMP)","volume":"27","author":"Chiu","year":"2012","journal-title":"J. Bone Miner. Res."},{"issue":"1","key":"10.1016\/j.bcp.2019.113762_b0150","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.febslet.2013.11.022","article-title":"HtrA1 is upregulated during RANKL-induced osteoclastogenesis, and negatively regulates osteoblast differentiation and BMP2-induced Smad1\/5\/8, ERK and p38 phosphorylation","volume":"588","author":"Wu","year":"2014","journal-title":"FEBS Lett."},{"issue":"1","key":"10.1016\/j.bcp.2019.113762_b0155","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.bone.2011.10.028","article-title":"Receptor activator of NF-kappaB ligand-dependent expression of caveolin-1 in osteoclast precursors, and high dependency of osteoclastogenesis on exogenous lipoprotein","volume":"50","author":"Hada","year":"2012","journal-title":"Bone"},{"issue":"6","key":"10.1016\/j.bcp.2019.113762_b0160","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.biochi.2010.02.007","article-title":"Prostaglandin E synthases: understanding their pathophysiological roles through mouse genetic models","volume":"92","author":"Hara","year":"2010","journal-title":"Biochimie"},{"issue":"3","key":"10.1016\/j.bcp.2019.113762_b0165","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.4049\/jimmunol.177.3.1879","article-title":"Membrane-bound prostaglandin E synthase-1-mediated prostaglandin E2 production by osteoblast plays a critical role in lipopolysaccharide-induced bone loss associated with inflammation","volume":"177","author":"Inada","year":"2006","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.bcp.2019.113762_b0170","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1073\/pnas.1522891113","article-title":"A dynamic Asp-Arg interaction is essential for catalysis in microsomal prostaglandin E2 synthase","volume":"113","author":"Brock","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcp.2019.113762_b0175","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ebiom.2018.05.008","article-title":"Inhibition of microsomal prostaglandin E Synthase-1 in cancer-associated fibroblasts suppresses neuroblastoma tumor growth","volume":"32","author":"Kock","year":"2018","journal-title":"EBioMedicine"},{"issue":"3","key":"10.1016\/j.bcp.2019.113762_b0180","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1677\/joe.0.158r001","article-title":"Important role of EP4, a subtype of prostaglandin (PG) E receptor, in osteoclast-like cell formation from mouse bone marrow cells induced by PGE2","volume":"158","author":"Ono","year":"1998","journal-title":"J. Endocrinol."},{"issue":"3","key":"10.1016\/j.bcp.2019.113762_b0185","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18030495","article-title":"TNFalpha increases RANKL expression via PGE(2)-induced activation of NFATc1","volume":"18","author":"Park","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.bcp.2019.113762_b0190","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.bcp.2013.04.015","article-title":"Potent inhibition of human 5-lipoxygenase and microsomal prostaglandin E2 synthase-1 by the anti-carcinogenic and anti-inflammatory agent embelin","volume":"86","author":"Schaible","year":"2013","journal-title":"Biochem. Pharmacol."},{"issue":"369","key":"10.1016\/j.bcp.2019.113762_b0195","doi-asserted-by":"crossref","first-page":"369ra176","DOI":"10.1126\/scitranslmed.aaj1921","article-title":"Aggregatibacter actinomycetemcomitans-induced hypercitrullination links periodontal infection to autoimmunity in rheumatoid arthritis","volume":"8","author":"Konig","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bcp.2019.113762_b0200","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ejphar.2016.02.057","article-title":"Herbacetin inhibits RANKL-mediated osteoclastogenesis in vitro and prevents inflammatory bone loss in vivo","volume":"777","author":"Li","year":"2016","journal-title":"Eur. J. Pharmacol."},{"issue":"10","key":"10.1016\/j.bcp.2019.113762_b0205","doi-asserted-by":"crossref","first-page":"706","DOI":"10.14348\/molcells.2017.0225","article-title":"Current understanding of RANK signaling in osteoclast differentiation and maturation","volume":"40","author":"Park","year":"2017","journal-title":"Mol. Cells"},{"issue":"3","key":"10.1016\/j.bcp.2019.113762_b0210","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.bbrc.2008.10.076","article-title":"Cell fusion in osteoclasts plays a critical role in controlling bone mass and osteoblastic activity","volume":"377","author":"Iwasaki","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.bcp.2019.113762_b0215","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1194\/jlr.R200005-JLR200","article-title":"Caveolins and macrophage lipid metabolism","volume":"44","author":"Gargalovic","year":"2003","journal-title":"J. Lipid Res."},{"issue":"1","key":"10.1016\/j.bcp.2019.113762_b0220","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1080\/09687860500460041","article-title":"Membrane microdomains, caveolae, and caveolar endocytosis of sphingolipids","volume":"23","author":"Cheng","year":"2006","journal-title":"Mol. Membr. Biol."},{"key":"10.1016\/j.bcp.2019.113762_b0225","doi-asserted-by":"crossref","DOI":"10.1038\/emm.2015.77","article-title":"Caveolin-1 regulates osteoclast differentiation by suppressing cFms degradation","volume":"47","author":"Lee","year":"2015","journal-title":"Exp. Mol. Med."},{"issue":"10","key":"10.1016\/j.bcp.2019.113762_b0230","doi-asserted-by":"crossref","first-page":"6522","DOI":"10.1074\/jbc.M114.598581","article-title":"Caveolin-1 regulates osteoclastogenesis and bone metabolism in a sex-dependent manner","volume":"290","author":"Lee","year":"2015","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.bcp.2019.113762_b0235","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1124\/pr.59.3.1","article-title":"Membrane prostaglandin E synthase-1: a novel therapeutic target","volume":"59","author":"Samuelsson","year":"2007","journal-title":"Pharmacol. Rev."},{"issue":"5","key":"10.1016\/j.bcp.2019.113762_b0240","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1039\/C7FO00210F","article-title":"Oleuropein down-regulated IL-1beta-induced inflammation and oxidative stress in human synovial fibroblast cell line SW982","volume":"8","author":"Castejon","year":"2017","journal-title":"Food Funct."},{"key":"10.1016\/j.bcp.2019.113762_b0245","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.bcp.2017.07.010","article-title":"Suppressing mPGES-1 expression by sinomenine ameliorates inflammation and arthritis","volume":"142","author":"Zhou","year":"2017","journal-title":"Biochem. Pharmacol."},{"issue":"11","key":"10.1016\/j.bcp.2019.113762_b0250","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0050244","article-title":"Lipopolysaccharide-induced expression of microsomal prostaglandin E synthase-1 mediates late-phase PGE2 production in bone marrow derived macrophages","volume":"7","author":"Xiao","year":"2012","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.bcp.2019.113762_b0255","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1111\/jcmm.12814","article-title":"Aminothiazoles inhibit RANKL- and LPS-mediated osteoclastogenesis and PGE2 production in RAW 264.7 cells","volume":"20","author":"Kats","year":"2016","journal-title":"J. Cell Mol. Med."},{"issue":"2","key":"10.1016\/j.bcp.2019.113762_b0260","doi-asserted-by":"crossref","DOI":"10.3390\/nu11020368","article-title":"Beta-cryptoxanthin inhibits lipopolysaccharide-induced osteoclast differentiation and bone resorption via the suppression of inhibitor of NF-kappaB kinase activity","volume":"11","author":"Hirata","year":"2019","journal-title":"Nutrients"},{"issue":"7722","key":"10.1016\/j.bcp.2019.113762_b0265","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/s41586-018-0482-7","article-title":"Coupling of bone resorption and formation by RANKL reverse signalling","volume":"561","author":"Ikebuchi","year":"2018","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.bcp.2019.113762_b0270","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/art.27204","article-title":"Nonsteroidal antiinflammatory drugs and prostaglandin E(2) modulate the synthesis of osteoprotegerin and RANKL in the cartilage of patients with severe knee osteoarthritis","volume":"62","author":"Moreno-Rubio","year":"2010","journal-title":"Arthritis. Rheum."},{"issue":"6","key":"10.1016\/j.bcp.2019.113762_b0275","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1093\/rheumatology\/kes363","article-title":"Delphinidin inhibits IL-1beta-induced activation of NF-kappaB by modulating the phosphorylation of IRAK-1(Ser376) in human articular chondrocytes","volume":"52","author":"Haseeb","year":"2013","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"10.1016\/j.bcp.2019.113762_b0280","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1002\/art.22081","article-title":"IKKbeta inhibition protects against bone and cartilage destruction in a rat model of rheumatoid arthritis","volume":"54","author":"Schopf","year":"2006","journal-title":"Arthritis. Rheum."},{"issue":"49","key":"10.1016\/j.bcp.2019.113762_b0285","doi-asserted-by":"crossref","first-page":"17438","DOI":"10.1073\/pnas.1418516111","article-title":"IKKbeta is an IRF5 kinase that instigates inflammation","volume":"111","author":"Ren","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295219304617?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295219304617?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T13:12:00Z","timestamp":1757769120000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295219304617"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":57,"alternative-id":["S0006295219304617"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2019.113762","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A mutation of cysteine 46 in IKK-\u03b2 promotes mPGES-1 and caveolin-1 expression to exacerbate osteoclast differentiation and osteolysis","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2019.113762","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113762"}}